CAI FY 2012 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$174M+38.4% YoY

Gross Profit

$126M72.2% margin

Operating Income

$91M52.1% margin

Net Income

$63M36.5% margin

EPS (Diluted)

$3.18

Cash Flow

Operating Cash Flow

$107M

Free Cash Flow

-$418M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$1.0B

Stockholders' Equity

$347M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174M	$126M	+38.4%
Gross Profit	$126M	$120M	+4.5%
Operating Income	$91M	$64M	+40.9%
Net Income	$63M	$50M	+26.5%